Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amvac acquires Corteva's quizalofop

US agrochemical company America Vanguard (Newport Beach, California) has acquired the quizalofop (QPE) herbicide line from DowDuPont's agricultural business, Corteva Agriscience.

US agrochemical company America Vanguard (Newport Beach, California) has acquired the quizalofop (QPE) herbicide line from DowDuPont's agricultural business, Corteva Agriscience. The deal covers technical registrations, commercial sales information and the transfer of existing product supply arrangements. Amvac has acquired rights to market quizalofop herbicides in Argentina and Chile, in line with its strategy to increase market access in South America.

The main markets for quizalofop are canola, soybeans and pulses in the US and Canada. "Our acquisition of the QPE product line from Corteva Agriscience provides our crop protection business with a portfolio of valuable herbicide brands that hold significant leadership positions in the North American market," says Amvac chairman and CEO Eric Wintemute. "These products are complementary to existing glyphosate, glufosinate and 2,4-D use, and are highly regarded for weed and grass control by providing a broad window of application and excellent crop safety," he adds.

In addition, Corteva's genetically modified herbicide-tolerant Enlist maize provides tolerance to quizalofop. Amvac has secured a licence to market quizalofop for use alone or with Enlist herbicides for "over-the-top" use on Enlist maize, the company points out. That segment is forecast to grow considerably, it adds.
Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG030669

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel